Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bone Mass Density
Bone mass distribution with antiresorptive agents positively affects structural strength
October 27th, 2005
Improvements in bone mass distribution with antiresorptive agents positively affect structural strength and stability. "Fracture reduction is only partially explained by increased BMD. The aim of a study" by scientists in the United States "was to examine changes in structural geometry of the hip, derived from DXA in postmenopausal women after treatment with antiresorptive agents." S. L. Greenspan and colleagues conducted "a double-blind, placebo-controlled, randomized clinical trial of 373 women over the age of 65 years, who were randomized to hormone replacement therapy, alendronate, combination therapy, or placebo for 3 years. The outcomes...
Source: Women's Health Weekly (2005-10-27)
|
